StockData
AdaptHealth Corp. logo

AdaptHealth Corp. (AHCO) company profile

AHCONasdaqServices-Home Health Care ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3044% below fair value
$7.53−0.20 (-2.59%)

Close on Nov 17, 2026Market cap $1.03BP/E –Yield –

About AdaptHealth

Services-Home Health Care Services, SIC 8082

AdaptHealth Corp. provides home healthcare solutions, medical equipment, and related supplies directly to patients. The company operates through four reportable segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. Its offerings include sleep therapy devices, oxygen and mechanical ventilation systems, continuous glucose monitors, insulin pumps, and home medical supplies for individuals managing chronic conditions or recovering after hospital discharge. Its customer base consists of patients covered by Medicare, Medicaid, and commercial health insurance plans, receiving referrals from hospitals, specialized clinics, and physicians.

The company operates across the United States, delivering products and services to approximately 4.3 million patients annually in all 50 states. Its distribution network comprises roughly 640 leased facilities located across 48 states, supported by approximately 10,900 employees who complete an average of 38,500 daily deliveries. AdaptHealth maintains its principal executive offices in Conshohocken, Pennsylvania.

Summary of the business section of AdaptHealth's latest annual report, written by StockData.

Company profile

Company

Legal name
AdaptHealth Corp.
Headquarters
Conshohocken, PA
Address
555 East North Lane, Suite 5075 19428
Phone
(610) 424-4515
Employees
10,900, Dec 31, 2025
Industry
Services-Home Health Care Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KPMG LLP, Philadelphia, Pennsylvania

Stock & identifiers

Ticker
AHCO
Exchange
Nasdaq
IPO date
Feb 15, 2018
Shares outstanding
136M, Jul 31, 2026
Public float
$1.04B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1725255
CUSIP
00653Q102
ISIN
US00653Q1022
FIGI
BBG00KJQVGV3
Share class FIGI
BBG00KJQVGW2
LEI
549300SN58QQ28RVWE26
EIN
82-3677704

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Suzanne FosterChief Executive Officer, Director924,050
Harriss T. CurrieCHIEF FINANCIAL OFFICER0
III Russell E. SchusterChief Commercial Officer125,263
Daniel Edward McFaddenChief Operating Officer103,376
Albert A. PrastChief Technology Officer338,712
Richard W. Rew IICLO and General Counsel107,097
Christine E. ArchboldChief Accounting Officer107,198
Toby Scott BarnhartChief Operating Officer220,654
Jason A. ClemensChief Financial Officer673,481
Dale B. WolfDirector177,234
Kenneth A. SametDirector48,569
David Solomon Williams IIIDirector64,044
Bradley J. CoppensDirector96,345
Theodore B. LundbergDirector892,495
Terence J. ConnorsDirector95,262
Gregory BelinfantiDirector104,269
Susan T. WeaverDirector113,817
Diana L. NoleDirector33,045

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$10.26M$9.60M$3.42M$27$110
FY2024
Mr Richard Barasch
$2.07M$2.06M$4.12M$25$93
FY2024
Ms.Suzanne Foster
$8.39M$8.35M$4.12M$25$93
FY2023
Mr Richard Barasch
$2.27M$2.05M$2.44M$19$92
FY2023
Mr Stephen Griggs
$10.44M$1.89M$2.44M$19$92
FY2022$4.72M$4.30M$2.82M$51$87

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Suzanne Foster
Chief Executive Officer
$1.00M–$7.53M$1.39M$330.67K$10.26M+22%
Jason Clemens
Chief Financial Officer
$670.00K–$3.50M$778.70K$10.68K$4.96M-22%
Toby Scott Barnhart
Chief Operating Officer
$600.00K–$1.75M$697.35K$516$3.05M+126%
Russell Schuster
Chief Commercial Officer
$450.00K$100.00K$1.89M$523.01K$8.46K$2.97M–
Albert Prast
Chief Technology Officer
$450.00K–$1.75M$523.01K$1.61K$2.72M-5%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Feb 15, 2018
Offer price
$10.00
Securities offered
25,000,000
Gross proceeds
$250.00M
Exchange
Nasdaq
First trading day
Apr 16, 2018
First-day close
$9.78-2.2%
Lock-up ends (est.)
Oct 13, 2018

“Each unit has an offering price of $10.00 and consists of one share of our common stock and one-third of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, AdaptHealth had approximately 10,900 employees.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?